M A Giembycz

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

Paul M. Seldon, Peter J. Barnes, Koremu Meja et al. · Molecular Pharmacology · 1995 · 132 citations

Characterization of eosinophil cell activation by peptides. Differential effects of substance P, melittin, and FMET-Leu-Phe.

Claus Kroegel, M A Giembycz, Peter J. Barnes · The Journal of Immunology · 1990 · 97 citations · Full text

Neuropeptides, Immunotoxicology, Eosinophil Cell Activation +22

Suppression of human eosinophil respiratory burst and cyclic AMP hydrolysis by inhibitors of type IV phosphodiesterase: interaction with the beta adrenoceptor agonist albuterol.

Gordon Dent, M A Giembycz, Pat Evans et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 82 citations

Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat

David Crawley, Lei Zhao, M A Giembycz et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 1992 · 65 citations

Cgmp-dependent Protein Kinase, Pulmonary Arterial Hypertension, Tissue Cgmp Levels +13

Inhibition of allergen-induced lung eosinophilia by type-III and combined type III- and IV-selective phosphodiesterase inhibitors in Brown-Norway rats

Wayne Elwood, J Sun, Peter J. Barnes et al. · Inflammation Research · 1995 · 36 citations

Asthma, Brown-norway Rats, Inflammatory Lung Disease +14